Devicia

Devicia was a Sweden-based clinical research and regulatory services company focused on medical devices and in vitro diagnostics. The company operated as a specialized CRO and consulting partner, providing services spanning medical writing, clinical investigations, regulatory affairs, and related clinical and preclinical support for MedTech products. Devicia served device and IVD manufacturers across the product life cycle rather than developing its own therapeutic pipeline. In October 2022, Devicia was acquired by Veranex as part of a broader transaction involving Clarvin and affiliated MedTech services companies, and it now appears to operate within the Veranex organization rather than as an independent active company.